Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
about
Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome.Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.B cell depletion in autoimmune disease.Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance.Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.Treatment with rituximab in benign and malignant hematologic disorders in children.Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.Prompt remission of severe SLE with only three doses of rituximab infusion and low dose steroid: the first case report from Indonesia.Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.CD20-mediated apoptosis: signalling through lipid rafts.Treatment of severe proliferative lupus nephritis: the current state.B lymphocytes and systemic lupus erythematosus.B cells in autoimmune diabetesEfficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?Novel therapies in lupus nephritis.Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimatedThe management of pediatric systemic lupus erythematosus.The biology behind the new therapies for SLE.Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.Anti-CD79 antibody induces B cell anergy that protects against autoimmunity.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission.Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.Life threatening steroid-resistant autoimmune anemia successfully treated with rituximab: a case report.SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody).Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.Improvement of refractory rheumatoid arthritis after depletion of B cells.A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide aloneSuccessful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus
P2860
Q33358261-20239E54-4429-43FD-9881-223F5AF91979Q33359900-FC07C708-BC79-4479-908B-D3E7F7842EEBQ33361142-905DC381-DBCC-42A0-BB94-2373B8A0C598Q33364913-A3406C2E-9598-44BE-818B-216BD9E792C8Q33366172-B995A081-CE5C-4C08-9F45-A5043A21B6DBQ33374660-5E88F36F-AC9B-4D2D-B524-94D6D788F164Q33375264-879ADF04-007F-412E-BEF1-B3B0F2D41DFAQ33382447-417B1357-F63A-4EC8-865E-A58A6692137BQ34369159-2F07233A-8A95-4659-8F11-9734FF6031B5Q34969960-2E684B91-94D9-4B01-A99C-0EC65F9EEC4DQ35201234-7E5EDD38-8786-4E41-AB7B-68A5D6376743Q35553367-D1C28F02-619E-46F4-9E89-72DB12833C86Q35612697-B08C0693-0D43-46DB-AA06-38DDFF7C493DQ35760171-E3E664CB-2F6D-4879-AB01-2BF10D8A6637Q35824478-6EF9D226-CCCE-4E28-BDEA-B4DECC5FC63AQ36054877-24AD2FF5-BE3F-4FA9-A67B-07C9D2D178A6Q36220079-D566944A-8B7D-40B3-BF65-11A98DDCC1EEQ36577380-F6D1CDF0-72F2-4486-866F-1E9540CC78ACQ36998921-8F52A2C3-8836-4DB3-8966-B69C8B6DE863Q37118531-A6451A1B-6DB1-4008-BCF2-152D5A5AB79EQ37541561-211CE6B8-0B45-4D7D-9CAB-CCDC6A5D13F0Q37616437-5037023D-D959-4CA5-BECA-CA68DE632B80Q37954539-C42ED891-C29A-4245-BBA0-46D7F82A4178Q43808725-23D35601-73E7-4CD3-BE6D-9FB16C3FD467Q45880555-B6CC8BF2-A832-4483-87AD-D3F7F9AAEB63Q46076323-F1A58385-31CF-4E37-918C-AF8DECAB94F8Q46165426-FA460386-5597-4347-B072-05AA508DF4E5Q46758012-EA1A911F-B836-4D44-B2CE-51A34D7B4301Q46815725-A560C5B0-85C7-4C26-AF73-F2A6FA4C859FQ47430048-B47C247B-7B1E-4682-997C-287F3C429BA8Q47690234-C11B3C8D-0DEE-48F6-B3F2-D56800BCE7EDQ53845558-64FEC953-ECF1-46C3-9BEE-F2660DB31D38Q57350420-B97887A4-F75D-4FDD-B461-44EBFA93BED8Q58302441-52F8933C-4455-418C-AE62-A771FFC67D24
P2860
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Anti-CD20 monoclonal antibody ...... systemic lupus erythematosus.
@en
type
label
Anti-CD20 monoclonal antibody ...... systemic lupus erythematosus.
@en
prefLabel
Anti-CD20 monoclonal antibody ...... systemic lupus erythematosus.
@en
P2093
P1476
Anti-CD20 monoclonal antibody ...... systemic lupus erythematosus.
@en
P2093
Angela La Manna
Bruno Nobili
Lucia Cennamo
Piero De Stefano
Silverio Perrotta
P304
P356
10.1046/J.1365-2141.2002.03278.X
P407
P577
2002-02-01T00:00:00Z